PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Part of paid clinical trials in Huntsville, Alabama.
- Sponsor
- Edwards Lifesciences
- Study ID
- NCT04889872
- Status
- Recruiting
Conditions
- Aortic Stenosis, Calcific
- Aortic Valve Stenosis
Eligibility Criteria
- Sex
- ALL
- Age
- 65 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA — DEVICEPatients will be implanted with a SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA heart valve
Study Details
This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects with moderate, calcific aortic stenosis. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
Key Dates
- Start date
- Oct 12, 2021
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2029
- Completion
- Jun 30, 2037
Study Design
- Enrollment
- 2,250 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TAVRTranscatheter Aortic Valve Replacement (TAVR)
- No Intervention: CSClinical Surveillance (CS)
Primary Outcome Measure
Primary Effectiveness Endpoint [ Time Frame: 2 years ]
Central Contacts
- Edwards THV Clinical Affairs949-250-2500
Locations (65)
Find similar trials in Huntsville, AL
Related Studies
- Imaging Histone Deacetylase in the HeartRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesRecruiting · Edwards Lifesciences · Newport Beach, California
- Effect of Fetal Aortic Valvuloplasty on OutcomesRecruiting · Queen Silvia Children's Hospital, Gothenburg, Sweden · San Francisco, California
- Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVRRecruiting · Institut universitaire de cardiologie et de pneumologie de Québec, University Laval · San Francisco, California